|
rdfs:label
|
"Gamma-aminobutyric acid type A receptor beta3 subunit"@nl
"Gamma-aminobutyric acid type A receptor subunit beta3"@en
|
|
skos:altLabel
|
"GABA(A) receptor subunit beta-3"@en
|
|
"GABA-alpha receptor beta-2 subunit"@en
|
|
"GABAA receptor beta-3 subunit"@en
|
|
"GABRB3"@en
|
|
"gamma-aminobutyric acid (GABA) A receptor, beta 3"@en
|
|
"gamma-aminobutyric acid A receptor beta 3"@en
|
|
"gamma-aminobutyric acid receptor subunit beta-3"@en
|
|
"gamma-aminobutyric acid type A receptor beta3 subunit"@en
|
|
schema:description
|
"humanes Protein"@de
"mammalian protein found in Homo sapiens"@en
"menselijk eiwit"@nl
"protein"@sv
"protein"@id
"proteinë"@sq
"protèin"@ace
"protéine humaine"@fr
"білок людини"@uk
"بروتين بشري"@ar
|
|
schema:dateModified
|
"2024-06-08T01:15:43+00:00"^^xsd:dateTime
|
|
schema:version
|
2174114292
|
|
wikibase:identifiers
|
22
|
|
wikibase:sitelinks
|
0
|
|
wikibase:statements
|
101
|
|
p:P129
|
wd:statement/Q21113312-0603191B-9599-4714-BB4D-DB77907F3DF9
|
|
wd:statement/Q21113312-0C07741B-8452-46E4-A419-D484A0E7914F
|
|
wd:statement/Q21113312-1C42E02C-FB5A-4AA5-8738-7D70EB0322EC
|
|
wd:statement/Q21113312-1E2DACE2-7D2B-4B65-9360-D19A11EBD5B1
|
|
wd:statement/Q21113312-23CCD606-9CF9-4616-9E73-2DB3EF4044AD
|
|
wd:statement/Q21113312-24047D28-5181-4698-AC37-AEBFDB4D26A7
|
|
wd:statement/Q21113312-50B48665-3277-4378-A04D-E3E8BE9D7298
|
|
wd:statement/Q21113312-64873205-AB4E-4175-8A9F-6921CA8A59DD
|
|
wd:statement/Q21113312-74FF418D-541E-447E-8775-C2651E2C2B32
|
|
wd:statement/Q21113312-7D514A61-59E8-4344-B7CC-D101A7C7C06E
|
|
wd:statement/Q21113312-7F2F81DF-465B-46D7-AAED-32822E6F7F6F
|
|
wd:statement/Q21113312-8EF5EE3A-40C2-4D0A-AE11-561789C8F96E
|
|
wd:statement/Q21113312-B671546A-D11F-428F-95AA-CA65B56FB579
|
|
wd:statement/Q21113312-BA073D9E-81AD-4E34-8F9E-5F46BE617E04
|
|
wd:statement/Q21113312-BCF5B302-4614-4D7E-8AB8-DA69E7D84D37
|
|
wd:statement/Q21113312-CEAF2FAA-9023-4966-8D24-16EDFB696D10
|
|
p:P279
|
wd:statement/Q21113312-EE2145EC-A355-49DC-9493-71020AA4B67A
|
|
p:P31
|
wd:statement/Q21113312-9E0E5B6E-24E4-471C-9F05-6829E82556E2
|
|
p:P352
|
wd:statement/Q21113312-554225CF-E96D-4978-BEC3-FAC01EB057A0
|
|
p:P361
|
wd:statement/Q21113312-270E7374-B2EC-47F4-ADFE-1F5D172CBC07
|
|
wd:statement/Q21113312-5448752E-946F-4D59-850C-3CA28C4AD38E
|
|
wd:statement/Q21113312-63089E9F-48B5-4EA6-9396-B12C310725C2
|
|
wd:statement/Q21113312-73C79940-DEDF-4F58-B463-C2ACA00542FD
|
|
wd:statement/Q21113312-8339D3A7-4F2C-42A3-B791-68A59C83D8B5
|
|
wd:statement/Q21113312-B3714EE1-D97F-439C-8ED3-AA93D1958A1D
|
|
wd:statement/Q21113312-B66EE509-E20F-4B29-9D0C-11C3C0EA542A
|
|
p:P527
|
wd:statement/Q21113312-0F02B608-F9BC-4592-ABF5-517B65C6F933
|
|
wd:statement/Q21113312-5CA1282F-3813-48B0-A95C-A78FF03C6396
|
|
wd:statement/Q21113312-E1A255B6-9F3D-4387-B5A6-1D0D5906AA2F
|
|
p:P637
|
wd:statement/Q21113312-025E9353-83A8-494D-AD95-B03BA85BF076
|
|
wd:statement/Q21113312-0EECD59C-B9D2-481B-9AD3-9469CB06A560
|
|
wd:statement/Q21113312-2F1A1EB0-E6CA-434A-A0E0-BD558F7E0562
|
|
wd:statement/Q21113312-8224DAA8-660D-41D0-8280-7BD81677C999
|
|
wd:statement/Q21113312-CEEF3E69-3726-4DE7-B792-7F8FEBC65BD4
|
|
wd:statement/Q21113312-F59CEF58-0A53-4F12-8D72-CD2D28C76DB1
|
|
p:P638
|
wd:statement/Q21113312-A0564E9E-0A8F-42B8-A4D1-C80EA75157D0
|
|
p:P680
|
wd:statement/Q21113312-1C30C87C-F88E-48D4-B43D-EC6FF379012E
|
|
wd:statement/Q21113312-1EE2A953-3307-4C05-8E16-CD01274ED98C
|
|
wd:statement/Q21113312-480DE538-F02C-4EDB-B284-5DC99FE2BB66
|
|
wd:statement/Q21113312-699489C8-12F4-4BD3-BDA5-92D40E0C3C88
|
|
wd:statement/Q21113312-6D8E36D4-9231-44EF-AC45-5C9C0E4FBC98
|
|
wd:statement/Q21113312-87E71956-93D8-4AA1-972A-E0EABF59C613
|
|
wd:statement/Q21113312-8A35D169-FEC9-45CC-A4C2-84214F0CE476
|
|
wd:statement/Q21113312-8C251934-82D1-4A24-911E-78D620956C24
|
|
wd:statement/Q21113312-A9C704DA-B094-406E-858E-DEA3B529BFFC
|
|
wd:statement/Q21113312-B38DAFCF-BAB5-4F22-8695-1EBDEE12D0E0
|
|
p:P681
|
wd:statement/Q21113312-098C5F32-5AF6-461C-9236-DA9DBE7C1A27
|
|
wd:statement/Q21113312-0BA7F416-FEDA-430E-8A0B-8F5EA33CF0CA
|
|
wd:statement/Q21113312-0C164DE0-0DB9-40BF-8279-64F433D95C12
|
|
wd:statement/Q21113312-0E222001-84FC-432A-9779-73B0B6B6FFF2
|
|
wd:statement/Q21113312-18CCB426-40B7-4E48-A5D4-550D1315E3AF
|
|
wd:statement/Q21113312-21CC6D45-2119-4E04-AA08-946CC242675E
|
|
wd:statement/Q21113312-230B6885-C756-40EB-8FE2-91B17DEB21E9
|
|
wd:statement/Q21113312-2CBC673B-3781-451A-94CA-5131890736C5
|
|
wd:statement/Q21113312-4F44AD75-970D-41D8-ADD5-93AF0EF64513
|
|
wd:statement/Q21113312-C020ADEB-7666-429D-B1B0-2FCB9673BCFD
|
|
wd:statement/Q21113312-C8BA7E09-0A09-4110-B946-B137768E4CE7
|
|
wd:statement/Q21113312-CBBFE1F1-67F8-4A4E-9E23-B080D2306CCA
|
|
wd:statement/Q21113312-D81B1BAA-93F2-4EF3-A785-5B1C12CB343C
|
|
wd:statement/Q21113312-DF17E0C6-0983-4F13-9EA4-87AED7D019EF
|
|
wd:statement/Q21113312-EBBBFB16-9130-42CD-B0A4-1115AB056390
|
|
wd:statement/Q21113312-FBC4970D-DF4C-405B-8F01-230EC98A8375
|
|
p:P682
|
wd:statement/Q21113312-09C07C90-59B6-4425-8DE7-3B9E11997980
|
|
wd:statement/Q21113312-216795AF-E0B3-4BD6-BFAA-24C7F027D9BD
|
|
wd:statement/Q21113312-46040563-2B58-4B72-89CD-368DCA67F6C7
|
|
wd:statement/Q21113312-56BF9B4F-70C8-410A-A928-B05F298308BC
|
|
wd:statement/Q21113312-5F20FCB8-86FF-4DC9-93A8-8D73D4C544EC
|
|
wd:statement/Q21113312-78ED9221-0C7C-4BE8-9D96-9A70A8682317
|
|
wd:statement/Q21113312-84A9DB09-8D23-4D3C-BCB6-D1A721A8B630
|
|
wd:statement/Q21113312-8B62D389-5BE9-4E29-BB68-7F131917407C
|
|
wd:statement/Q21113312-96D91B91-77B6-433C-ABE5-03D5A624DFF7
|
|
wd:statement/Q21113312-97F449F8-B3C6-4096-ABEF-2CF2D80D02C1
|
|
wd:statement/Q21113312-9DEE5BE6-944C-4E25-97EE-1AD0020ED2E6
|
|
wd:statement/Q21113312-B4DE2EDE-4532-497E-A774-0CD13DC9ED41
|
|
wd:statement/Q21113312-B646FCD7-D6F3-4335-9DB2-3EEBA21B1DD0
|
|
wd:statement/Q21113312-C0A5E146-8E91-4D86-ABF1-20E785F367AB
|
|
wd:statement/Q21113312-C0F81E6D-0D77-44AE-AE68-C5B668675D6E
|
|
wd:statement/Q21113312-C7ABA424-ED36-44E6-B2DF-038C33B1D910
|
|
wd:statement/Q21113312-C8D7DA13-55C8-49F3-A996-4BEA0A2083C7
|
|
wd:statement/Q21113312-DA904351-AE21-4846-B445-0EDF47ADD565
|
|
wd:statement/Q21113312-E30FA0B7-5059-4B65-8BD1-9F39F169592C
|
|
wd:statement/Q21113312-E5C81921-B730-470F-9A6D-69D4B0ABAD24
|
|
wd:statement/Q21113312-E9D49D3F-655D-4DB5-A4A5-04EC145B2423
|
|
wd:statement/Q21113312-F2525C28-8E7B-466E-88E9-986BBCBEA9D8
|
|
wd:statement/Q21113312-F6C6F872-7860-49A6-BD43-598353D9133A
|
|
p:P702
|
wd:statement/Q21113312-4C5B8BE7-DBA4-4D43-879C-FE7FFE13361A
|
|
p:P703
|
wd:statement/Q21113312-0D5F4908-41E1-4E35-9B54-513E29980D22
|
|
p:P705
|
wd:statement/Q21113312-0200A957-DBA0-47DA-B50A-BBE3E788C5B2
|
|
wd:statement/Q21113312-3CD15CED-C8C8-4BB1-9A0E-BB4A445710BA
|
|
wd:statement/Q21113312-4AD59C39-BB89-43E2-9728-E37D88721B55
|
|
wd:statement/Q21113312-4DD7DA1C-AEBB-4887-BE1F-DEFE95F6C047
|
|
wd:statement/Q21113312-50A76E81-EAAE-4C07-BC5F-52B0384834F7
|
|
wd:statement/Q21113312-9283AFD1-1B1A-4068-9B46-17B51940035E
|
|
wd:statement/Q21113312-935CFF0E-4818-44C1-AE8B-43C973A41C20
|
|
wd:statement/Q21113312-A01AC3AF-199D-42BC-88FB-C67E85154CAF
|
|
wd:statement/Q21113312-A69FA24E-A85E-4083-A232-0478EA939AB2
|
|
wd:statement/Q21113312-D8E95C75-1B67-442F-89BB-416860B5D44C
|
|
wd:statement/Q21113312-DF41F3E3-1073-40FE-BAB8-963AB5B4DED0
|
|
wd:statement/Q21113312-E4FE2EE9-1752-4CDB-B080-7673A249D31A
|
|
wd:statement/Q21113312-EAFDC320-3149-4501-AC94-D32339465515
|
|
p:P7260
|
wd:statement/Q21113312-A803800D-98C1-4653-A95C-107A9D94B9D1
|
|
p:direct-normalized/P352
|
<http://purl.uniprot.org/uniprot/P28472>
|
|
p:direct-normalized/P637
|
<http://purl.uniprot.org/refseq/NP_000805>
|
|
<http://purl.uniprot.org/refseq/NP_001178249>
|
|
<http://purl.uniprot.org/refseq/NP_001178250>
|
|
<http://purl.uniprot.org/refseq/NP_001265560>
|
|
<http://purl.uniprot.org/refseq/NP_068712>
|
|
<http://purl.uniprot.org/refseq/XP_011519730>
|
|
p:direct-normalized/P638
|
<https://rdf.wwpdb.org/pdb/4COF>
|
|
wdt:P129
|
metharbital
|
|
triclofos
|
|
butalbital
|
|
chlordiazepoxide
|
|
diazepam
|
|
prazepam
|
|
zopiclone
|
|
topiramate
|
|
clotiazepam
|
|
allopregnanolone
|
|
chlordiazepoxide hydrochloride
|
|
clorazepate dipotassium
|
|
methohexital sodium
|
|
pentobarbital sodium
|
|
picrotoxin
|
|
etazolate
|
|
wdt:P279
|
cysteine loop ligand-gated ion channel receptor
|
|
wdt:P31
|
protein
|
|
wdt:P352
|
"P28472"
|
|
wdt:P361
|
Gamma-aminobutyric-acid A receptor, beta subunit
|
|
Neurotransmitter-gated ion-channel transmembrane domain superfamily
|
|
Neurotransmitter-gated ion-channel ligand-binding domain superfamily
|
|
GABAA receptor
|
|
Neurotransmitter-gated ion-channel ligand-binding domain, protein family
|
|
Neurotransmitter-gated ion-channel transmembrane domain, protein family
|
|
Neurotransmitter-gated ion-channel, conserved site, protein family
|
|
wdt:P527
|
Neurotransmitter-gated ion-channel, conserved site
|
|
Neurotransmitter-gated ion-channel ligand-binding domain
|
|
Neurotransmitter-gated ion-channel transmembrane domain
|
|
wdt:P637
|
"NP_000805"
|
|
"NP_001178249"
|
|
"NP_001178250"
|
|
"NP_001265560"
|
|
"NP_068712"
|
|
"XP_011519730"
|
|
wdt:P638
|
"4COF"
|
|
wdt:P680
|
identical protein binding
|
|
transmembrane signaling receptor activity
|
|
chloride channel activity
|
|
ion channel activity
|
|
extracellular ligand-gated ion channel activity
|
|
GABA-A receptor activity
|
|
GABA-gated chloride ion channel activity
|
|
transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential
|
|
wdt:P681
|
integral component of membrane
|
|
membrane
|
|
neuron projection
|
|
cytoplasmic vesicle
|
|
integral component of plasma membrane
|
|
cytoplasmic vesicle membrane
|
|
postsynaptic membrane
|
|
chloride channel complex
|
|
synapse
|
|
cell junction
|
|
GABA-A receptor complex
|
|
GABA-ergic synapse
|
|
plasma membrane
|
|
wdt:P682
|
inhibitory postsynaptic potential
|
|
chemical synaptic transmission
|
|
regulation of neuron apoptotic process
|
|
negative regulation of neuron apoptotic process
|
|
ion transport
|
|
roof of mouth development
|
|
negative regulation of neuron death
|
|
chloride transport
|
|
ion transmembrane transport
|
|
regulation of membrane potential
|
|
neuron development
|
|
cellular response to histamine
|
|
cochlea development
|
|
nervous system process
|
|
chloride transmembrane transport
|
|
hearing
|
|
inner ear receptor cell development
|
|
gamma-aminobutyric acid signaling pathway
|
|
inhibitory synapse assembly
|
|
innervation
|
|
signal transduction
|
|
wdt:P702
|
GABRB3
|
|
wdt:P703
|
man
|
|
wdt:P705
|
"ENSP00000299267"
|
|
"ENSP00000308725"
|
|
"ENSP00000383049"
|
|
"ENSP00000439169"
|
|
"ENSP00000442408"
|
|
"ENSP00000451077"
|
|
"ENSP00000452041"
|
|
"ENSP00000452159"
|
|
"ENSP00000481004"
|
|
"ENSP00000486819"
|
|
"ENSP00000489768"
|
|
"ENSP00000489940"
|
|
"ENSP00000490678"
|
|
wdt:P7260
|
"1.A.9.5.4"
|